SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Early Stage Parkinson Disease
Interventions
DRUG

Pardaprunox

12-42 mg

DRUG

pramipexole

1.5-4.5 mg

DRUG

Placebo Comparator

Placebo

Trial Locations (89)

Unknown

419, Birmingham

413, Oceanside

408, Oxnard

422, New Haven

403, Boca Raton

411, Sarasota

421, Augusta

410, Fort Wayne

417, Lexington

405, Boston

420, Boston

415, Grand Rapids

416, Golden Valley

406, Minneapolis

418, Albany

424, Charlotte

412, Raleigh

303, Bedford Park

304, Cheltenham

301, Concord

302, Westmead

315, Kralove

313, Olomouc

310, Ostrava

314, Ostrava

312, Pardubice

311, Pilsen

320, Tallinn

321, Tartu

323, Aix-en-Provence

324, Toulon

325, Toulouse

332, Bochum

331, Göttingen

329, Heidelberg

327, Homburg

330, Leipzig

328, Lübeck

326, Wiesbaden

338, Bangalore

339, Hyderabad

337, Kerala

336, Mumbai

340, Mumbai

347, Arcugnano (VI)

348, Grosseto GR

346, Lido Di Camaiore (LU)

344, Pescara

343, Roma

345, Roma

428, Kaunas

427, Vilnius

429, Vilnius

355, Kelantan

357, Kuala Lumpur

356, Pulau Pinang

361, 's-Hertogenbosch

364, Eindhoven

363, Emmen

362, Groningen

360, RM Groningen

373, Gdansk

371, Kalisz

369, Katowice

374, Katowice

365, Krakow

368, Leszno

366, Lublin

370, Mosina

367, Torun

376, Coimbra

375, Lisbon

377, Cape Town

378, Cape Town

380, Gauteng

381, Pretoria

379, Sandton

383, Barcelona

384, Colmenar Viejo

382, Donostia / San Sebastian

388, Hualien City

387, Kaohsiung City

389, Kaohsiung Hsien

386, Kweishan

385, Taipei

391, Bangkok

393, Bangkok

394, Ubonratchathani Province

396, Blackpool

All Listed Sponsors
lead

Solvay Pharmaceuticals

INDUSTRY

NCT00335166 - SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease | Biotech Hunter | Biotech Hunter